|
NUDT5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.69980000022763E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.516300E-03 |
| Normal-vs-Stage2 |
2.992200E-02 |
| Normal-vs-Stage3 |
1.139050E-03 |
| Normal-vs-Stage4 |
2.822400E-03 |
| Stage1-vs-Stage2 |
6.257000E-01 |
| Stage1-vs-Stage3 |
4.559300E-03 |
| Stage1-vs-Stage4 |
7.73070000000819E-05 |
| Stage2-vs-Stage3 |
7.620400E-03 |
| Stage2-vs-Stage4 |
1.392060E-02 |
| Stage3-vs-Stage4 |
6.183800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.23769999979839E-07 |
| Normal-vs-AfricanAmerican |
5.103500E-02 |
| Normal-vs-Asian |
8.886100E-02 |
| Caucasian-vs-AfricanAmerican |
6.209800E-01 |
| Caucasian-vs-Asian |
1.563220E-01 |
| AfricanAmerican-vs-Asian |
1.249760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.790250E-04 |
| Normal-vs-Female |
2.32309999999014E-05 |
| Male-vs-Female |
1.397970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.143700E-03 |
| Normal-vs-Extreme_Weight |
2.698700E-03 |
| Normal-vs-Obese |
3.140700E-03 |
| Normal-vs-Extreme_Obese |
5.106200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.424600E-01 |
| Normal_Weight-vs-Obese |
5.293200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.934000E-01 |
| Extreme_Weight-vs-Obese |
4.012400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.792620E-01 |
| Obese-vs-Extreme_Obese |
6.538000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.778460E-02 |
| Normal-vs-Age(41-60Yrs) |
4.011100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.990490E-04 |
| Normal-vs-Age(81-100Yrs) |
1.365170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.465800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.804500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.190300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.385700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.223600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.253800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.484500E-02 |
| Normal-VS-Type2 PRCC |
5.71659999999419E-05 |
| Normal-VS-KIRP CIMP |
5.556600E-03 |
| Normal-VS-Unclassified PRCC |
9.032800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.797300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.233800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.839580E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.529600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.863800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.333800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.043200E-03 |
| Normal-vs-N1 |
7.855600E-03 |
| Normal-vs-N2 |
3.696400E-01 |
| N0-vs-N1 |
7.256400E-02 |
| N0-vs-N2 |
5.468600E-01 |
| N1-vs-N2 |
9.381000E-01 |
|
|
